[Should we propose a systematic second transurethral resection of the bladder for all high-risk non-muscle invasive
A Lipsker1, Y Hammoudi1, B Parier1
1Service d'urologie, hôpital Bicêtre, AP-HP, université Paris XI, Paris-Sud, 78, rue du Général-Leclerc, 94270 Le Kremlin-Bicêtre, France.
Objective:
Quantify the rate of residual bladder tumor following systematic second look resection of pTa high-grade versus pT1 high-grade patients.
Material And Methods:
From January 2010 to July 2013, 53 patients with a non-muscle-invasive bladder cancer with high-risk of recurrence and progression underwent a second systematic resection in accordance with the current guidelines of the French Association of Urology (AFU).
Results:
Among the 53 patients with a high-risk non-muscle-invasive bladder cancer, histological examination of the initial resection identified: 17 pTa high-grade (32.1%) and 36 pT1 high-grade (67.9%). There was a significant difference between the 2 groups of patients (Ta high-grade versus T1 high-grade) concerning the rate of residual tumor on second look resection (11.8% versus 66.7%, P=0.0002). The predictive factors of residual tumor after second resection were the pT1 stage (P=0.0002), tumor multifocality (P=0.02) and presence of associated Cis (P=0.0005).
Conclusion:
The high rate of residual tumor in our series confirmed the importance of a systematic second look resection for high-risk non-muscle-invasive bladder cancers. However, for the pTa tumors without associated Cis, the interest of this second look seemed of less concern.
Level Of Evidence:
5.
More Related Videos
08:43An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
Published on: July 28, 2012
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Related Concept Videos
Urinary Tract Calculi VI: Surgical Management
Anatomy of the Genitourinary System II: Bladder and Urethra
Kidney Transplant II: Surgical Procedure
Imaging Studies II: Ultrasonography
Urologic Endoscopic Procedure: Cystoscopic Examination
